BioLife Solutions reported second-quarter earnings of $0.04 per share, surpassing the Zacks Consensus Estimate of a loss of $0.01 per share and marking an earnings surprise of 500 percent. Revenue came in at $28.47 million, beating the consensus by 1.48 percent and up from $25.42 million a year ago. The company has now topped consensus EPS and revenue estimates in each of the last four quarters. Shares have gained about 39.8 percent year-to-date, outpacing the S&P 500's 12.8 percent advance.
BioLife Solutions IncBeat Q2 EPS and revenue estimates, marking fourth consecutive quarter of beating estimates.
Agilent Technologies Inc